Difference between revisions of "Thyroid cytopathology"

Thyroid cytopathology (view source)

61 bytes added , 14:48, 3 March 2011

m

48,536

edits

@@ Line 22: / Line 22: @@
 ===Bethesda (2009)===
-The NCI classification of 2008 was revised in 2009 and dubbed "The Bethesda System for Reporting Thyroid Cytopathology":<ref name=pmid19888858>{{cite journal |author=Cibas ES, Ali SZ |title=The Bethesda System for Reporting Thyroid Cytopathology |journal=Thyroid |volume=19 |issue=11 |pages=1159–65 |year=2009 |month=November |pmid=19888858 |doi=10.1089/thy.2009.0274 |url=}}</ref>
+This is formally known as the "The Bethesda System for Reporting Thyroid Cytopathology"; it is based on the NCI classification of 2008:<ref name=pmid19888858>{{cite journal |author=Cibas ES, Ali SZ |title=The Bethesda System for Reporting Thyroid Cytopathology |journal=Thyroid |volume=19 |issue=11 |pages=1159–65 |year=2009 |month=November |pmid=19888858 |doi=10.1089/thy.2009.0274 |url=}}</ref>
 {| class="wikitable"
 |-
@@ Line 35: / Line 35: @@
 | Follow-up, clinical
 |-
-| Follicular lesion of undetermined significance (FLUS) ''or'' atypia of undetermined significance
+| Follicular lesion of undetermined significance (FLUS)<br> ''or'' atypia of undetermined significance
 | Uncertain, favour benign
 | 5-15%
 | Repeat FNA
 |-
-| Follicular neoplasm ''or'' suspicious for follicular neoplasm
+| Follicular neoplasm<br> ''or'' suspicious for follicular neoplasm; if oncocytic type it should be noted
 | Uncertain, favour malignant
 | 15-30%